Literature DB >> 16682737

Colorectal cancer model of health disparities: understanding mortality differences in minority populations.

Blase N Polite1, James J Dignam, Olufunmilayo I Olopade.   

Abstract

African Americans are more likely to be diagnosed with and die as a result of colorectal cancer than white patients. This review briefly documents these differences and explores the factors that may contribute to advanced stage at diagnosis and reduced survival once African Americans are diagnosed with colorectal cancer. Attention is focused on what is known about the role of socioeconomic status, cancer screening, comorbidities and lifestyle factors, tumor biology and genetics, and the differences in the receipt of and benefit of appropriate therapy. Finally, areas of ongoing and future research and policy initiatives aimed at reducing disparities are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16682737     DOI: 10.1200/JCO.2005.05.4775

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  75 in total

1.  Lower albumin levels in African Americans at colon cancer diagnosis: a potential explanation for outcome disparities between groups?

Authors:  Aja S McCutchen; Juan Carlos Munoz; Lacie Brenner; Peter Wludyka; Kenneth J Vega
Journal:  Int J Colorectal Dis       Date:  2011-01-27       Impact factor: 2.571

2.  Race and subset analyses in clinical trials: time to get serious about data integration.

Authors:  Blase N Polite; Brooke E Sylvester; Olufunmilayo I Olopade
Journal:  J Natl Cancer Inst       Date:  2011-10-12       Impact factor: 13.506

3.  Racial disparities in stage-specific colorectal cancer mortality: 1960-2005.

Authors:  Samir Soneji; Shally Shalini Iyer; Katrina Armstrong; David A Asch
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

4.  Demographic and other characteristics of nodal non-Hodgkin's lymphoma managed in academic versus non-academic centers.

Authors:  Vijaya Raj Bhatt; Prajwal Dhakal; Sumit Dahal; Smith Giri; Ranjan Pathak; R Gregory Bociek; Peter T Silberstein; James O Armitage
Journal:  Ther Adv Hematol       Date:  2015-10

5.  Outcomes Among Minority Patients With Metastatic Colorectal Cancer in a Safety-net Health Care System.

Authors:  Kelsey Lau-Min; Preeti Prakash; Eunji Jo; Aaron P Thrift; Susan Hilsenbeck; Benjamin L Musher
Journal:  Clin Colorectal Cancer       Date:  2020-01-02       Impact factor: 4.481

6.  Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes.

Authors:  Terry Hyslop; David S Weinberg; Stephanie Schulz; Alan Barkun; Scott A Waldman
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

7.  What factors influence minority use of National Cancer Institute-designated cancer centers?

Authors:  Lyen C Huang; Yifei Ma; Justine V Ngo; Kim F Rhoads
Journal:  Cancer       Date:  2013-10-21       Impact factor: 6.860

Review 8.  Guanylyl cyclase C as a biomarker in colorectal cancer.

Authors:  Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

9.  Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.

Authors:  F Aminkeng; C J D Ross; S R Rassekh; L R Brunham; J Sistonen; M-P Dube; M Ibrahim; T B Nyambo; S A Omar; A Froment; J-M Bodo; S Tishkoff; B C Carleton; M R Hayden
Journal:  Pharmacogenomics J       Date:  2013-04-16       Impact factor: 3.550

10.  Characterizing Short-Term Outcomes Following Surgery for Rectal Cancer: the Role of Race and Insurance Status.

Authors:  Sook Y Chan; Pasithorn A Suwanabol; Rachelle N Damle; Jennifer S Davids; Paul R Sturrock; W Brian Sweeney; Justin A Maykel; Karim Alavi
Journal:  J Gastrointest Surg       Date:  2016-08-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.